D.E. Shaw & Co’s Boston Scientific BSX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q4 | – | Sell |
-15,000
| Closed | -$1.46M | – | 4609 |
|
|
2025
Q3 | $1.46M | Sell |
15,000
-108,000
| -88% | -$11.2M | ﹤0.01% | 3204 |
|
|
2025
Q2 | $13.2M | Buy |
123,000
+67,400
| +121% | +$6.82M | 0.01% | 1290 |
|
|
2025
Q1 | $5.61M | Buy |
+55,600
| New | +$5.6M | 0.01% | 1806 |
|
|
2024
Q3 | – | Sell |
-15,000
| Closed | -$1.16M | – | 4549 |
|
|
2024
Q2 | $1.16M | Buy |
+15,000
| New | +$1.1M | ﹤0.01% | 3090 |
|
|
2022
Q1 | – | Sell |
-20,000
| Closed | -$850K | – | 5553 |
|
|
2021
Q4 | $850K | Hold |
20,000
| – | – | ﹤0.01% | 4061 |
|
|
2021
Q3 | $868K | Hold |
20,000
| – | – | ﹤0.01% | 3720 |
|
|
2021
Q2 | $855K | Hold |
20,000
| – | – | ﹤0.01% | 3670 |
|
|
2021
Q1 | $773K | Hold |
20,000
| – | – | ﹤0.01% | 3285 |
|
|
2020
Q4 | $719K | Sell |
20,000
-75,000
| -79% | -$2.7M | ﹤0.01% | 3220 |
|
|
2020
Q3 | $3.63M | Sell |
95,000
-29,300
| -24% | -$1.13M | ﹤0.01% | 1930 |
|
|
2020
Q2 | $4.36M | Buy |
124,300
+104,300
| +522% | +$3.76M | 0.01% | 1747 |
|
|
2020
Q1 | $653K | Buy |
+20,000
| New | +$781K | ﹤0.01% | 3049 |
|
|
2015
Q1 | – | Sell |
-58,400
| Closed | -$774K | – | 3641 |
|
|
2014
Q4 | $774K | Hold |
58,400
| – | – | ﹤0.01% | 3013 |
|
|
2014
Q3 | $690K | Sell |
58,400
-20,000
| -26% | -$252K | ﹤0.01% | 3107 |
|
|
2014
Q2 | $1M | Hold |
78,400
| – | – | ﹤0.01% | 2948 |
|
|
2014
Q1 | $1.06M | Hold |
78,400
| – | – | ﹤0.01% | 2978 |
|
|
2013
Q4 | $942K | Buy |
78,400
+8,500
| +12% | +$100K | ﹤0.01% | 3224 |
|
|
2013
Q3 | $821K | Buy |
+69,900
| New | +$756K | ﹤0.01% | 3217 |
|
Other funds holding BSX
VCM
VPM
